Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Di Giovanni

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Current Topics in Medicinal Chemistry|August 12, 2008
New ligands at 5-HT and DA receptors for the treatment of neuropsychiatric disordersGiuseppe Di Giovanni
CNS Neuroscience & Therapeutics|June 19, 2010
Dopamine interaction with other neurotransmitter systems: Relevance in the pathophysiology and treatment of CNS disordersGiuseppe Di Giovanni
CNS & Neurological Disorders Drug Targets|October 18, 2011
Editorial: nitric oxide: implications for the etiology and treatment of central nervous system disordersGiuseppe Di Giovanni
Journal of Neural Transmission. Supplementum|April 24, 2010
A diet for dopaminergic neurons?Giuseppe Di Giovanni
Experimental Brain Research|September 24, 2013
Serotonin in the pathophysiology and treatment of CNS disordersGiuseppe Di Giovanni
CNS & Neurological Disorders Drug Targets|February 22, 2008
Will it ever become possible to prevent dopaminergic neuronal degeneration?Giuseppe Di Giovanni
Experimental Brain Research|April 18, 2013
Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functionsCristiano Bombardi, Giuseppe Di Giovanni
International Journal of Molecular Sciences|July 12, 2025
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to TherapyGloria Montebello, Giuseppe Di Giovanni
CNS Neuroscience & Therapeutics|November 12, 2015
Differential Control by 5-HT and 5-HT1A, 2A, 2C Receptors of Phasic and Tonic GABAA Inhibition in the Visual ThalamusVincenzo Crunelli, Giuseppe Di Giovanni
Journal of Neuroscience Methods|October 18, 2017
Editorial on Special Issue: Animal models of Tourette syndromeMarco Bortolato, Giuseppe Di Giovanni
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Current Topics in Medicinal Chemistry|August 12, 2008
New ligands at 5-HT and DA receptors for the treatment of neuropsychiatric disordersGiuseppe Di Giovanni
CNS Neuroscience & Therapeutics|June 19, 2010
Dopamine interaction with other neurotransmitter systems: Relevance in the pathophysiology and treatment of CNS disordersGiuseppe Di Giovanni
CNS & Neurological Disorders Drug Targets|October 18, 2011
Editorial: nitric oxide: implications for the etiology and treatment of central nervous system disordersGiuseppe Di Giovanni
Journal of Neural Transmission. Supplementum|April 24, 2010
A diet for dopaminergic neurons?Giuseppe Di Giovanni
Experimental Brain Research|September 24, 2013
Serotonin in the pathophysiology and treatment of CNS disordersGiuseppe Di Giovanni
CNS & Neurological Disorders Drug Targets|February 22, 2008
Will it ever become possible to prevent dopaminergic neuronal degeneration?Giuseppe Di Giovanni
Experimental Brain Research|April 18, 2013
Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functionsCristiano Bombardi, Giuseppe Di Giovanni
International Journal of Molecular Sciences|July 12, 2025
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to TherapyGloria Montebello, Giuseppe Di Giovanni
CNS Neuroscience & Therapeutics|November 12, 2015
Differential Control by 5-HT and 5-HT1A, 2A, 2C Receptors of Phasic and Tonic GABAA Inhibition in the Visual ThalamusVincenzo Crunelli, Giuseppe Di Giovanni
Journal of Neuroscience Methods|October 18, 2017
Editorial on Special Issue: Animal models of Tourette syndromeMarco Bortolato, Giuseppe Di Giovanni
Pageof 19